Donald H. Marks

3.4k total citations
29 papers, 854 citations indexed

About

Donald H. Marks is a scholar working on Parasitology, Epidemiology and Cell Biology. According to data from OpenAlex, Donald H. Marks has authored 29 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Parasitology, 5 papers in Epidemiology and 5 papers in Cell Biology. Recurrent topics in Donald H. Marks's work include Hemoglobin structure and function (5 papers), Vector-borne infectious diseases (4 papers) and Blood transfusion and management (3 papers). Donald H. Marks is often cited by papers focused on Hemoglobin structure and function (5 papers), Vector-borne infectious diseases (4 papers) and Blood transfusion and management (3 papers). Donald H. Marks collaborates with scholars based in United States, Canada and Thailand. Donald H. Marks's co-authors include Edwin L. Cooper, Dung‐Tsa Chen, Zhongkai Shi, Jianfeng Zhang, De‐chu C. Tang, K. Wade Foster, Peng Gao, Craig A. Elmets, Elizabeth Stein and Kent R. Van Kampen and has published in prestigious journals such as New England Journal of Medicine, European Journal of Immunology and Vaccine.

In The Last Decade

Donald H. Marks

28 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald H. Marks United States 12 409 339 172 161 121 29 854
Edward I. Shaw United States 14 249 0.6× 212 0.6× 130 0.8× 281 1.7× 65 0.5× 33 1.0k
J L Perret France 10 406 1.0× 304 0.9× 83 0.5× 77 0.5× 102 0.8× 17 757
Annette Dougall Australia 13 315 0.8× 303 0.9× 137 0.8× 164 1.0× 53 0.4× 13 845
V. Jiménez-Lucho United States 11 301 0.7× 209 0.6× 64 0.4× 146 0.9× 40 0.3× 16 633
Richard W. Finley United States 15 287 0.7× 265 0.8× 66 0.4× 152 0.9× 49 0.4× 31 955
Irma Aguilar-Delfín Mexico 10 496 1.2× 740 2.2× 144 0.8× 92 0.6× 289 2.4× 14 1.0k
Charles S. Pavia United States 23 676 1.7× 696 2.1× 448 2.6× 174 1.1× 158 1.3× 74 1.4k
F B Cogswell United States 18 316 0.8× 387 1.1× 178 1.0× 140 0.9× 69 0.6× 28 1.2k
Josipa Kuleš Croatia 17 222 0.5× 272 0.8× 65 0.4× 60 0.4× 90 0.7× 67 911
MG Collett New Zealand 16 141 0.3× 252 0.7× 50 0.3× 103 0.6× 127 1.0× 64 943

Countries citing papers authored by Donald H. Marks

Since Specialization
Citations

This map shows the geographic impact of Donald H. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald H. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald H. Marks more than expected).

Fields of papers citing papers by Donald H. Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald H. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald H. Marks. The network helps show where Donald H. Marks may publish in the future.

Co-authorship network of co-authors of Donald H. Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Donald H. Marks. A scholar is included among the top collaborators of Donald H. Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald H. Marks. Donald H. Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marks, Donald H., et al.. (2014). Drug-induced liver disease: Primer for the primary care physician. Disease-a-Month. 60(2). 55–104. 11 indexed citations
2.
Marks, Donald H.. (2011). Neurological complications of vaccination with outer surface protein A (OspA). International Journal of Risk & Safety in Medicine. 23(2). 89–96. 2 indexed citations
3.
Marks, Donald H.. (2008). Cardiomyopathy Due to Ingestion of Adderall. American Journal of Therapeutics. 15(3). 287–289. 8 indexed citations
4.
Marks, Donald H., et al.. (2008). Homicidal Ideation Causally Related to Therapeutic Medications. Ethical Human Psychology and Psychiatry. 10(3). 134–145. 2 indexed citations
5.
Marks, Donald H., et al.. (2007). Use of fMRI to predict psychiatric adverse effects of interferon treatment for Hepatitis C - preliminary report.. PubMed. 3(5). 655–67. 4 indexed citations
6.
Kampen, Kent R. Van, Zhongkai Shi, Peng Gao, et al.. (2004). Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine. 23(8). 1029–1036. 177 indexed citations
7.
Kanesa-thasan, Niranjan, Donald H. Marks, Eiji Konishi, et al.. (2000). Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus — poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans. Vaccine. 19(4-5). 483–491. 85 indexed citations
8.
Sigal, Leonard H., John M. Zahradnik, Philip T. Lavin, et al.. (1998). A Vaccine Consisting of RecombinantBorrelia burgdorferiOuter-Surface Protein A to Prevent Lyme Disease. New England Journal of Medicine. 339(4). 216–222. 283 indexed citations
9.
Keller, David, et al.. (1994). Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine.. PubMed. 271(22). 1764–8. 76 indexed citations
10.
Marks, Donald H., et al.. (1989). Effect of Polymyxin B on Hemoglobin-mediated Hepatotoxicity. Military Medicine. 154(4). 180–184. 6 indexed citations
11.
Marks, Donald H., et al.. (1988). Removal of Bacteria from Blood by Charcoal Hemoperfusion. Biomaterials Artificial Cells and Artificial Organs. 16(1-3). 135–140. 11 indexed citations
12.
Marks, Donald H., Gerald L. Moore, F. Medina, et al.. (1988). Optimization of Synthesis of Pyridoxalated Polymerized Stroma-free Hemoglobin Solution. Military Medicine. 153(1). 44–49. 12 indexed citations
13.
Marks, Donald H., et al.. (1987). Antibody Response To Transfusion With Pyridoxalated Polymerized Hemoglobin Solution. Military Medicine. 152(9). 473–477. 16 indexed citations
14.
Marks, Donald H., et al.. (1987). Pyridoxalated Polymerized Stroma-Free Hemoglobin Solution (SFHS-PP) as an Oxygen-Carrying Fluid Replacement for Hemorrhagic Shock in Dogs. Military Medicine. 152(5). 265–271. 7 indexed citations
15.
Marks, Donald H., et al.. (1983). Stroma-Free Methemoglobin Solution as an Antidote for Cyanide Poisoning: A Preliminary Study. Journal of Toxicology Clinical Toxicology. 21(3). 343–358. 5 indexed citations
16.
Marks, Donald H., Elizabeth Stein, & Edwin L. Cooper. (1981). Acid phosphatase changes associated with response to foreign tissue in the earthworm Lumbricus terrestris. Comparative Biochemistry and Physiology Part A Physiology. 68(4). 681–683. 6 indexed citations
17.
Marks, Donald H., Elizabeth Stein, & Edwin L. Cooper. (1979). Chemotactic attraction of Lumbricus terrestris coelomocytes to foreign tissue. Developmental & Comparative Immunology. 3. 277–285. 8 indexed citations
18.
Linthicum, D. Scott, Donald H. Marks, Elizabeth Stein, & Edwin L. Cooper. (1977). Graft rejection in earthworms: an electron microscopic study. European Journal of Immunology. 7(12). 871–876. 25 indexed citations
19.
Marks, Donald H. & Edwin L. Cooper. (1977). Aeromonas hydrophila in the Coelomic Cavity of the Earthworms Lumbricus terrestris and Eisenia foetida. Journal of Invertebrate Pathology. 29(3). 382–383. 11 indexed citations
20.
Linthicum, D. Scott, Elizabeth Stein, Donald H. Marks, & Edwin L. Cooper. (1977). Electron-microscopic observations of normal coelomocytes from the earthworm, Lumbricus terrestris. Cell and Tissue Research. 185(3). 315–30. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026